|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.1 USD | +3.01% |
|
+7.81% | +25.83% |
| 07-15 | Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing | MT |
| 07-12 | China approves CSPC Pharma's RSV vaccine for clinical trials | RE |
Jan 11 (Reuters) -
* WHO ENCOURAGES COVID-19 VACCINE MANUFACTURERS TO GENERATE AND PROVIDE DATA ON PERFORMANCE OF CURRENT, OMICRON-SPECIFIC COVID-19 VACCINES - STATEMENT
* WHO SAYS VACCINE MANUFACTURERS ARE ALSO ENCOURAGED TO PROVIDE SUCH DATA FOR ANY NOVEL, BROADLY REACTIVE SARS-COV-2 VACCINES THAT ARE DEVELOPED
* WHO SAYS ADVISORY GROUP WILL CONTINUE TO ASSESS EVIDENCE ON PREDOMINANT CIRCULATING VARIANT WITH RESPECT TO PROPERTIES OF SPREAD/TRANSMISSIBILITY Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| +25.83% | 47.96B | |
| +46.23% | 41.47B | |
| +0.69% | 42.45B | |
| +30.52% | 31.6B | |
| +22.30% | 28.63B | |
| -6.35% | 28.03B | |
| +49.25% | 14.56B | |
| +49.18% | 14.14B | |
| +3.45% | 12.58B | |
| -3.85% | 11.71B |
MODERNA, INC. 
